The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.

Side by side

Compound comparison

Check interactions →Open as saved/share list

HGH / Somatropin

FDA-approved · Grade C

Goals
muscle, healing, sleep, weight-loss
Evidence
10 RCT / 3 animal / 2 in vitro
Routes
injectable-sc, injectable-im
WADA
S2
FDA
Approved
Cancer caution
hard-stop
Typical dose
Half-life
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

CIT Stack

Research chemical · Grade C

Goals
muscle, sleep, weight-loss
Evidence
0 RCT / 0 animal / 0 in vitro
Routes
injectable-sc
WADA
S2
FDA
Not approved
Cancer caution
caution
Typical dose
Half-life
The CIT Blend uses CJC-1295 WITHOUT DAC (also called Mod GRF 1-29) — the pulsatile form with ~30 min half-life
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

Human Chorionic Gonadotropin

FDA-approved · Grade B

Goals
hormonal, libido, muscle
Evidence
14 RCT / 0 animal / 0 in vitro
Routes
injectable-sc, injectable-im
WADA
S2
FDA
Approved
Cancer caution
hard-stop
Typical dose
Half-life
The 36-hour half-life of hCG vs LH's 30 minutes reflects the CTP extension's protective effect against renal clearance and plasma peptidase degradation
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

Sermorelin

FDA-approved · Grade C

Goals
muscle, sleep, weight-loss, hormonal
Evidence
0 RCT / 0 animal / 0 in vitro
Routes
injectable-sc
WADA
S2
FDA
Approved
Cancer caution
hard-stop
Typical dose
Half-life
Plasma half-life: approximately 10-12 minutes following subcutaneous injection — the shortest half-life of any major GHRH analog in common use
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →